1. Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN transcatheter heart valve for high-risk aortic stenosis patients 
Israel M. Barbash, MD, Danny Dvir, MD, Ron Waksman, MD 
American Heart Journal 
Volume 165, Issue 5, Pages (May 2013)
DOI: /j.ahj
Copyright © 2013 Mosby, Inc. Terms and Conditions

2. Figure
Complication rates of high-risk patients included in the PARTNER trial randomized to TAVR and the nonrandomized, single-arm registry of high-risk patients undergoing TAVR included in the CAP. Complication rates were much lower in the CAP than in the RCT: Stroke (3.1% vs 4.4%), major vascular complication (4.2% vs 11.1%), and major bleeding (4.6% vs 10.8%).
American Heart Journal  , DOI: ( /j.ahj )
Copyright © 2013 Mosby, Inc. Terms and Conditions